IT1276031B1 - Composizione farmaceutica per il trattamento delle malattie autoimmuni - Google Patents

Composizione farmaceutica per il trattamento delle malattie autoimmuni

Info

Publication number: IT1276031B1
Authority: IT; Italy
Prior art keywords: pharmaceutical composition; pct; treatment; autoimmune diseases; date
Prior art date: 1995-10-31

Application number

IT95MI002242A

Other languages

English (en)

Inventor

Angelo Guglielmotti

Paolo Dionisio

Original Assignee

Angelini Ricerche Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-10-31

Filing date

1995-10-31

Publication date

1997-10-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11372453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1276031(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-10-31 Application filed by Angelini Ricerche Spa filed Critical Angelini Ricerche Spa

1995-10-31 Priority to IT95MI002242A priority Critical patent/IT1276031B1/it

1995-10-31 Publication of ITMI952242A0 publication Critical patent/ITMI952242A0/it

1996-10-26 Priority to DK96937258T priority patent/DK0858337T3/da

1996-10-26 Priority to EP96937258A priority patent/EP0858337B1/en

1996-10-26 Priority to HK99103337.8A priority patent/HK1018219B/xx

1996-10-26 Priority to US09/068,011 priority patent/US6020356A/en

1996-10-26 Priority to TR1998/00765T priority patent/TR199800765T2/xx

1996-10-26 Priority to AT96937258T priority patent/ATE326965T1/de

1996-10-26 Priority to AU74938/96A priority patent/AU721841B2/en

1996-10-26 Priority to KR1019980703195A priority patent/KR19990067237A/ko

1996-10-26 Priority to PT96937258T priority patent/PT858337E/pt

1996-10-26 Priority to PL96326371A priority patent/PL186377B1/pl

1996-10-26 Priority to SK579-98A priority patent/SK284069B6/sk

1996-10-26 Priority to CA002236256A priority patent/CA2236256C/en

1996-10-26 Priority to ES96937258T priority patent/ES2264144T3/es

1996-10-26 Priority to EA199800417A priority patent/EA000826B1/ru

1996-10-26 Priority to SI9630737T priority patent/SI0858337T1/sl

1996-10-26 Priority to CNB96199472XA priority patent/CN1229113C/zh

1996-10-26 Priority to HU9901303A priority patent/HU228051B1/hu

1996-10-26 Priority to DE69636167T priority patent/DE69636167T2/de

1996-10-26 Priority to CZ19981326A priority patent/CZ292258B6/cs

1996-10-26 Priority to IL12429196A priority patent/IL124291A/en

1996-10-26 Priority to JP51705397A priority patent/JP4007615B2/ja

1996-10-26 Priority to PCT/EP1996/004672 priority patent/WO1997016185A2/en

1996-10-26 Priority to BRPI9611320-0A priority patent/BR9611320B1/pt

1996-10-26 Priority to NZ321580A priority patent/NZ321580A/en

1996-10-28 Priority to ZA969060A priority patent/ZA969060B/xx

1997-05-01 Publication of ITMI952242A1 publication Critical patent/ITMI952242A1/it

1997-10-24 Publication of IT1276031B1 publication Critical patent/IT1276031B1/it

1997-10-24 Application granted granted Critical

1998-04-29 Priority to NO19981951A priority patent/NO324130B1/no

1998-04-30 Priority to MX9803478A priority patent/MX9803478A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Immunology (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Transplantation (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Gastroenterology & Hepatology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

IT95MI002242A 1995-10-31 1995-10-31 Composizione farmaceutica per il trattamento delle malattie autoimmuni IT1276031B1 (it)

Priority Applications (28)

Application Number	Priority Date	Filing Date	Title
IT95MI002242A IT1276031B1 (it)	1995-10-31	1995-10-31	Composizione farmaceutica per il trattamento delle malattie autoimmuni
NZ321580A NZ321580A (en)	1995-10-31	1996-10-26	A pharmaceutical composition containing bindarit for the treatment of autoimmune diseases
ES96937258T ES2264144T3 (es)	1995-10-31	1996-10-26	Composicion farmaceutica para el tratameinto de enfermedades autoinmunes.
CNB96199472XA CN1229113C (zh)	1995-10-31	1996-10-26	用于治疗自身免疫性疾病的药物组合物
HK99103337.8A HK1018219B (en)	1995-10-31	1996-10-26	A pharmaceutical composition for the treatment of autoimmune diseases
US09/068,011 US6020356A (en)	1995-10-31	1996-10-26	Pharmaceutical composition for the treatment of autoimmune diseases
TR1998/00765T TR199800765T2 (xx)	1995-10-31	1996-10-26	Otoim�n hastal�klar�n tedavisine mahsus bir farmas�tik bile�im
AT96937258T ATE326965T1 (de)	1995-10-31	1996-10-26	Pharmazeutische zusammensetzung zur behandlung von autoimmunkrankheiten
AU74938/96A AU721841B2 (en)	1995-10-31	1996-10-26	A pharmaceutical composition for the treatment of autoimmune diseases
KR1019980703195A KR19990067237A (ko)	1995-10-31	1996-10-26	자기면역질환 치료용 제약학적 조성물
PT96937258T PT858337E (pt)	1995-10-31	1996-10-26	Composicao farmaceutica para o tratamento de doencas auto-imunes
PL96326371A PL186377B1 (pl)	1995-10-31	1996-10-26	Kompozycja farmaceutyczna do leczenia chorób autoimmunologicznych
SK579-98A SK284069B6 (sk)	1995-10-31	1996-10-26	Farmaceutický prípravok na liečenie autoimunitných patologických stavov
CA002236256A CA2236256C (en)	1995-10-31	1996-10-26	A pharmaceutical composition for the treatment of autoimmune diseases
DK96937258T DK0858337T3 (da)	1995-10-31	1996-10-26	Farmaceutisk præparat til behandling af autoimmune sygdomme
EA199800417A EA000826B1 (ru)	1995-10-31	1996-10-26	Фармацевтическая композиция для лечения аутоиммунных заболеваний
SI9630737T SI0858337T1 (sl)	1995-10-31	1996-10-26	Farmacevtski sestavek za zdravljenje avtoimunskihbolezni
EP96937258A EP0858337B1 (en)	1995-10-31	1996-10-26	A pharmaceutical composition for the treatment of autoimmune diseases
HU9901303A HU228051B1 (en)	1995-10-31	1996-10-26	A pharmaceutical composition for the treatment of autoimmune diseases
DE69636167T DE69636167T2 (de)	1995-10-31	1996-10-26	Pharmazeutische zusammensetzung zur behandlung von autoimmunkrankheiten
CZ19981326A CZ292258B6 (cs)	1995-10-31	1996-10-26	Farmaceutický prostředek pro léčení autoimunních chorob
IL12429196A IL124291A (en)	1995-10-31	1996-10-26	Pharmaceutical preparations containing bindrite and immunosuppressant for the treatment of autoimmune diseases
JP51705397A JP4007615B2 (ja)	1995-10-31	1996-10-26	自己免疫性疾患の処置用薬剤組成物
PCT/EP1996/004672 WO1997016185A2 (en)	1995-10-31	1996-10-26	A pharmaceutical composition for the treatment of autoimmune diseases
BRPI9611320-0A BR9611320B1 (pt)	1995-10-31	1996-10-26	composição farmacêutica compreendendo bidarit, um imunossurpressor selecionado a partir de ciclofosfamida, metilprednisolona, prednisolona e prednisona.
ZA969060A ZA969060B (en)	1995-10-31	1996-10-28	A pharmaceutical composition for the treatment of autoimmune diseases
NO19981951A NO324130B1 (no)	1995-10-31	1998-04-29	Farmasoytisk preparat for behandling av autoimmunsykdommer
MX9803478A MX9803478A (es)	1995-10-31	1998-04-30	Una composicion farmaceutica para el tratamiento de enfermedades autoinmunes.

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT95MI002242A IT1276031B1 (it)	1995-10-31	1995-10-31	Composizione farmaceutica per il trattamento delle malattie autoimmuni

Publications (3)

Publication Number	Publication Date
ITMI952242A0 ITMI952242A0 (it)	1995-10-31
ITMI952242A1 ITMI952242A1 (it)	1997-05-01
IT1276031B1 true IT1276031B1 (it)	1997-10-24

Family

ID=11372453

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT95MI002242A IT1276031B1 (it)	1995-10-31	1995-10-31	Composizione farmaceutica per il trattamento delle malattie autoimmuni

Country Status (26)

Country	Link
US (1)	US6020356A (it)
EP (1)	EP0858337B1 (it)
JP (1)	JP4007615B2 (it)
KR (1)	KR19990067237A (it)
CN (1)	CN1229113C (it)
AT (1)	ATE326965T1 (it)
AU (1)	AU721841B2 (it)
BR (1)	BR9611320B1 (it)
CA (1)	CA2236256C (it)
CZ (1)	CZ292258B6 (it)
DE (1)	DE69636167T2 (it)
DK (1)	DK0858337T3 (it)
EA (1)	EA000826B1 (it)
ES (1)	ES2264144T3 (it)
HU (1)	HU228051B1 (it)
IL (1)	IL124291A (it)
IT (1)	IT1276031B1 (it)
MX (1)	MX9803478A (it)
NO (1)	NO324130B1 (it)
NZ (1)	NZ321580A (it)
PL (1)	PL186377B1 (it)
PT (1)	PT858337E (it)
SK (1)	SK284069B6 (it)
TR (1)	TR199800765T2 (it)
WO (1)	WO1997016185A2 (it)
ZA (1)	ZA969060B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6323201B1 (en)	1994-12-29	2001-11-27	The Regents Of The University Of California	Compounds for inhibition of ceramide-mediated signal transduction
IT1293795B1 (it)	1997-07-28	1999-03-10	Angelini Ricerche Spa	Farmaco attivo nel ridurre la produzione di proteina mcp-1
ES2335008T3 (es) *	2003-04-24	2010-03-18	Jagotec Ag	Comprimido con nucleo coloreado.
DK2049123T4 (en)	2006-08-03	2016-11-28	Horizon Pharma Ag	LATE discharge-glucocorticoid treatment of rheumatoid ILLNESS
ITMI20062254A1 (it) *	2006-11-24	2008-05-25	Acraf	Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
TWI494108B (zh) *	2009-01-26	2015-08-01	Nitec Pharma Ag	糖皮質激素用以製備嚴重夜間氣喘用之於延遲釋放型的藥物之用途
DK2462118T3 (da)	2009-08-03	2014-08-25	Acraf	Fremgangsmåde til fremstilling af 1-benzyl-3-hydroxymethyl-1H-indazol og dets derivater og nødvendige magnesiummellemprodukter
UA108742C2 (uk) *	2009-09-23	2015-06-10		Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
US8999292B2 (en) *	2012-05-01	2015-04-07	Translatum Medicus Inc.	Methods for treating and diagnosing blinding eye diseases
DK2844250T3 (en) *	2012-05-01	2018-01-08	Translatum Medicus Inc	METHODS OF TREATMENT AND DIAGNOSTICATION OF EYE DISEASES CONCERNING BLINDNESS
EP3990433A4 (en)	2019-06-25	2023-07-26	Translatum Medicus Inc.	METHODS FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0477195A1 (en) *	1989-06-16	1992-04-01	The Upjohn Company	Suramin type compounds and angiostatic steroids to inhibit angiogenesis
IT1253703B (it) *	1991-04-22	1995-08-23	Angelini Francesco Ist Ricerca	Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
US5770589A (en) *	1993-07-27	1998-06-23	The University Of Sydney	Treatment of macular degeneration
AU7376494A (en) *	1993-08-04	1995-02-28	Andrulis Pharmaceuticals Corporation	Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents
US5434170A (en) *	1993-12-23	1995-07-18	Andrulis Pharmaceuticals Corp.	Method for treating neurocognitive disorders
MX9708620A (es) *	1995-05-10	1998-02-28	Pfizer	Combinacion de metotrexate y tenidap para el tratamiento de artritis reumatoide.

1995
- 1995-10-31 IT IT95MI002242A patent/IT1276031B1/it active IP Right Grant
1996
- 1996-10-26 PT PT96937258T patent/PT858337E/pt unknown
- 1996-10-26 JP JP51705397A patent/JP4007615B2/ja not_active Expired - Fee Related
- 1996-10-26 ES ES96937258T patent/ES2264144T3/es not_active Expired - Lifetime
- 1996-10-26 TR TR1998/00765T patent/TR199800765T2/xx unknown
- 1996-10-26 EP EP96937258A patent/EP0858337B1/en not_active Expired - Lifetime
- 1996-10-26 US US09/068,011 patent/US6020356A/en not_active Expired - Lifetime
- 1996-10-26 IL IL12429196A patent/IL124291A/en not_active IP Right Cessation
- 1996-10-26 DK DK96937258T patent/DK0858337T3/da active
- 1996-10-26 KR KR1019980703195A patent/KR19990067237A/ko not_active Ceased
- 1996-10-26 DE DE69636167T patent/DE69636167T2/de not_active Expired - Lifetime
- 1996-10-26 CZ CZ19981326A patent/CZ292258B6/cs unknown
- 1996-10-26 CA CA002236256A patent/CA2236256C/en not_active Expired - Lifetime
- 1996-10-26 BR BRPI9611320-0A patent/BR9611320B1/pt active IP Right Grant
- 1996-10-26 HU HU9901303A patent/HU228051B1/hu unknown
- 1996-10-26 SK SK579-98A patent/SK284069B6/sk not_active IP Right Cessation
- 1996-10-26 EA EA199800417A patent/EA000826B1/ru not_active IP Right Cessation
- 1996-10-26 WO PCT/EP1996/004672 patent/WO1997016185A2/en not_active Ceased
- 1996-10-26 PL PL96326371A patent/PL186377B1/pl unknown
- 1996-10-26 AU AU74938/96A patent/AU721841B2/en not_active Expired
- 1996-10-26 NZ NZ321580A patent/NZ321580A/en not_active IP Right Cessation
- 1996-10-26 CN CNB96199472XA patent/CN1229113C/zh not_active Expired - Lifetime
- 1996-10-26 AT AT96937258T patent/ATE326965T1/de active
- 1996-10-28 ZA ZA969060A patent/ZA969060B/xx unknown
1998
- 1998-04-29 NO NO19981951A patent/NO324130B1/no not_active IP Right Cessation
- 1998-04-30 MX MX9803478A patent/MX9803478A/es unknown

Also Published As

Publication number	Publication date
AU721841B2 (en)	2000-07-13
KR19990067237A (ko)	1999-08-16
ZA969060B (en)	1997-05-29
PL186377B1 (pl)	2003-12-31
NO981951D0 (no)	1998-04-29
SK57998A3 (en)	1998-12-02
DE69636167T2 (de)	2007-03-29
AU7493896A (en)	1997-05-22
WO1997016185A3 (en)	1997-07-03
IL124291A (en)	2001-06-14
ATE326965T1 (de)	2006-06-15
ITMI952242A0 (it)	1995-10-31
JP4007615B2 (ja)	2007-11-14
NO324130B1 (no)	2007-09-03
TR199800765T2 (xx)	1998-08-21
US6020356A (en)	2000-02-01
EP0858337B1 (en)	2006-05-24
BR9611320B1 (pt)	2010-08-10
CN1207042A (zh)	1999-02-03
WO1997016185A2 (en)	1997-05-09
NO981951L (no)	1998-06-29
HUP9901303A3 (en)	2001-04-28
CZ132698A3 (cs)	1998-10-14
JPH11515020A (ja)	1999-12-21
CA2236256C (en)	2005-02-22
PT858337E (pt)	2006-09-29
CZ292258B6 (cs)	2003-08-13
HU228051B1 (en)	2012-09-28
BR9611320A (pt)	1999-03-02
DK0858337T3 (da)	2006-09-18
HK1018219A1 (en)	1999-12-17
NZ321580A (en)	2000-02-28
CN1229113C (zh)	2005-11-30
EP0858337A2 (en)	1998-08-19
SK284069B6 (sk)	2004-09-08
EA199800417A1 (ru)	1998-10-29
DE69636167D1 (de)	2006-06-29
EA000826B1 (ru)	2000-04-24
HUP9901303A2 (hu)	1999-09-28
PL326371A1 (en)	1998-09-14
CA2236256A1 (en)	1997-05-09
ES2264144T3 (es)	2006-12-16
MX9803478A (es)	1998-11-30
ITMI952242A1 (it)	1997-05-01

Publication	Publication Date	Title
BG104620A (en)	2001-04-30	Oral pharmaceutical extended release dosage form
ES2128761T3 (es)	1999-05-16	Formulacion de tirilazad con cosolvente para administracion parenteral.
PT871465E (pt)	2003-02-28	Utilizacao de ritonavir (abt-538) para melhorar a farmacocinetica de drogas metabolizadas por citocromo p450 num metodo de tratamento da sida
WO2002041883A3 (en)	2003-12-18	As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation
ES2179040T3 (es)	2003-01-16	Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
NZ514574A (en)	2004-02-27	Novel method of treatment
IT1276031B1 (it)	1997-10-24	Composizione farmaceutica per il trattamento delle malattie autoimmuni
DE60102590T2 (de)	2005-04-21	Darreichungsformen zur behandlung von oralen mykosen
ATE235901T1 (de)	2003-04-15	Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen
SE9900070D0 (sv)	1999-01-13	New use
CA2217513A1 (en)	1996-10-10	Pharmaceutical agents for the treatment of alzheimer's disease
DE69518229D1 (de)	2000-09-07	Hustenhemmende zusammensetzung die ein antitussivum und benzydamin enthält
MXPA02011533A (es)	2003-04-25	Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
AP9901474A0 (en)	1999-03-31	Pharmaceutical composition for treating viral diseases.
DK0706395T3 (da)	2002-07-22	Lægemiddel med analgetisk effekt med minimal bevægelsesblokade
NO984651L (no)	1998-12-03	Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
DE69830176D1 (de)	2005-06-16	Arzneimittel gegen infertilität, die mit endometriose assoziiert ist
ATE293445T1 (de)	2005-05-15	Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
WO1998038985A3 (en)	1998-12-23	Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases
WO1998038986A3 (en)	1999-01-14	Use of carvedilol or derivatives thereof for the manufacture of a medicament for the prevention and treatment of viral infections
AP9200405A0 (en)	1994-01-13	Pharmaceutical formulations comprised of micronised halofantrine.
RU95111888A (ru)	1998-02-10	Способ лечения периферических поражений лицевого нерва
MX9706825A (es)	1997-11-29	El uso farmacologico de ciertos derivados de cistina.

Legal Events

Date	Code	Title	Description
1997-10-24	0001	Granted